» Articles » PMID: 21684837

Return to Work After Treatment for Breast Cancer: Single Center Experience in a Cohort of 273 Patients

Overview
Journal Bull Cancer
Publisher Elsevier
Specialty Oncology
Date 2011 Jun 21
PMID 21684837
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: An increasing number of patients is treated for breast cancer during their professional life. The aim of this study was to assess factors impacting return to work and time to return to work after treatment.

Patients And Methods: One thousand and sixty-seven patients less than 60 years of age, and surgically treated in our institution between January 1st, 2004 and December 31st, 2005 received a questionnaire with medical, sociodemographic and professional items. An answer was obtained in 586 cases. Two hundred and seventy-three patients were evaluable. All the clinical files of these patients were reviewed.

Results: Overall, 79.8% of the patients returned to work after a median delay of 11.5 months. In the multivariate analysis, the factors affecting the return to work were: age (P<0.0001), educational level (P<0.001), colleagues' support (P<0.001), chemotherapy (P<0.05), lymphedema (P<0.01), and the physical (P=0.01) and psychological (P<0.01) constraints of the job. The factors affecting the time until return to work were very quite similar. No significant difference was observed according to the type of surgery, radiation therapy or not, hormonotherapy or not.

Conclusion: Eighty percent of the patients with a professional activity before treatment returned to work; the factors affecting return to work were medical, demographic and socio-professional.

Citing Articles

Return to Activities of Daily Living after Breast Cancer Surgery: An Observational Prospective Questionnaire-Based Study of Patients Undergoing Mastectomy with or without Immediate Reconstruction.

Ballance L, Wilson R, Kirwan C, Boundouki G, Taxiarchi V, Baker B Breast J. 2023; 2023:9345780.

PMID: 37771428 PMC: 10533274. DOI: 10.1155/2023/9345780.


Acceptability and Feasibility of a Return-to-Work Intervention for Posttreatment Breast Cancer Survivors: Protocol for a Co-design and Development Study.

Bilodeau K, Gouin M, Lecours A, Lederer V, Durand M, Kilpatrick K JMIR Res Protoc. 2022; 11(4):e37009.

PMID: 35451972 PMC: 9077508. DOI: 10.2196/37009.


PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy.

Cognetti F, Masetti R, Fabi A, Bianchi G, Santini D, Rognone A NPJ Breast Cancer. 2021; 7(1):47.

PMID: 33953182 PMC: 8099872. DOI: 10.1038/s41523-021-00246-4.


Psychosocial Issues Associated with Breast Cancer-Related Lymphedema: a Literature Review.

Eaton L, Narkthong N, Hulett J Curr Breast Cancer Rep. 2020; 12(4):216-224.

PMID: 32864036 PMC: 7445072. DOI: 10.1007/s12609-020-00376-x.


Analysis of medico-social factors for return to work among patients presenting with haematological malignancy (adamantine): results of a 'pilot study'.

Clin B, Heutte N, Boulanger M, Troussard X, Cornet E, Damaj G BMC Res Notes. 2020; 13(1):313.

PMID: 32616070 PMC: 7331231. DOI: 10.1186/s13104-020-05149-4.